BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Entegrion Welcomes Peter C. Johnson, MD as Executive Vice President and Chief Business Officer


1/27/2009 2:02:21 PM

Research Triangle Park, N.C., January 27, 2009 Life sciences company Entegrion continues to strengthen its leadership team with the addition of Peter C. Johnson, MD, who will serve as Executive Vice President and Chief Business Officer, effective immediately. Dr. Johnson brings his unique background in surgery, thrombosis biology, corporate management and entrepreneurship to Entegrion at an ideal time in the Companys history.

Prior to joining Entegrion, Dr. Johnson was the Founder, President and CEO of Scintellix, LLC, a highly successful biomedical technology and decision analysis consultancy in Raleigh, NC. In addition to practicing Plastic Surgery for ten years at the University of Pittsburgh, Dr. Johnson founded and was the first President of the Pittsburgh Tissue Engineering Initiative. He then co-founded and was the Chairman and CEO of TissueInformatics. After its sale to Paradigm Genetics (which became Icoria), he served as the Senior Vice President for Life Sciences, Chief Medical Officer and Chief Business Officer of the merged entity.

We are delighted to have someone of Peters caliber on our team and look forward to working together to move our exciting platform of products forward, said Stan Eskridge, President and CEO.

Dr. Johnson serves on multiple for profit and non-profit boards. He is the National Chair for the University of North Carolina Medical Foundations Medical Excellence Fund and is the Co-Editor in Chief of the three part journal, Tissue Engineering. He is an avid fly fisherman, cook, artist and author.

Dr. Johnson received a BS degree from the University of Notre Dame, his MD from SUNY Upstate Medical University, trained in General Surgery at Case Western Reserve University and in Plastic Surgery at the University of Pittsburgh. He took a postdoctoral fellowship in thrombosis biology at Harvard University.

About Entegrion

Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, resuscitation and associated tissue repair. The company is based in North Carolinas Research Triangle Park, and is the inventor of Stasilon the hemostatic medical textile technology cleared by the FDA for use by prescription and also by consumers from which multiple hemorrhage control products are being made.

Building upon technologies licensed from the University of North Carolina, Entegrions portfolio includes platelet-derived platform technologies that are being developed as topical gels and sprays for tissue repair, infusible hemostatic agents for the control of internal hemorrhage, and novel vehicles for delivery of drugs to targeted tumors and other sites of internal bleeding. Entegrion has also developed proprietary techniques for drying plasma and other blood components to provide for long shelf life with rapid rehydration for emergent and clinical use. For more information, visit www.entegrion.com.

Read at BioSpace.com

Entegrion
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES